George Rathmann Dies

George Rathmann, Amgen's founding chief executive, has died, reports The New York Times. He was 84. Rathmann led Amgen in the 1980s while it developed what the Times calls "two of the most successful drugs in history" — Epogen and Neupogen. "He was the one who created the company, without any doubt," says Lowell Sears, a former chief financial officer at Amgen.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.